BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9973427)

  • 1. IL-18 up-regulates perforin-mediated NK activity without increasing perforin messenger RNA expression by binding to constitutively expressed IL-18 receptor.
    Hyodo Y; Matsui K; Hayashi N; Tsutsui H; Kashiwamura S; Yamauchi H; Hiroishi K; Takeda K; Tagawa Y; Iwakura Y; Kayagaki N; Kurimoto M; Okamura H; Hada T; Yagita H; Akira S; Nakanishi K; Higashino K
    J Immunol; 1999 Feb; 162(3):1662-8. PubMed ID: 9973427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous exposure to interleukin-18 and interleukin-10 in vitro synergistically augments murine spleen natural killer cell activity.
    Micallef MJ; Tanimoto T; Torigoe K; Nishida Y; Kohno K; Ikegami H; Kurimoto M
    Cancer Immunol Immunother; 1999; 48(2-3):109-17. PubMed ID: 10414464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The participation of the Fas-mediated cytotoxic pathway by natural killer cells is tumor-cell-dependent.
    Mori S; Jewett A; Murakami-Mori K; Cavalcanti M; Bonavida B
    Cancer Immunol Immunother; 1997 Jul; 44(5):282-90. PubMed ID: 9247563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of stimulatory factors on natural killer cell activities of young and aged mice.
    Nogusa S; Murasko DM; Gardner EM
    J Gerontol A Biol Sci Med Sci; 2012 Sep; 67(9):947-54. PubMed ID: 22454373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NK cells rapidly remove B16F10 tumor cells in a perforin and interferon-gamma independent manner in vivo.
    Grundy MA; Zhang T; Sentman CL
    Cancer Immunol Immunother; 2007 Aug; 56(8):1153-61. PubMed ID: 17160409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-12-responding asialoGM1+CD8+ central memory-type T cells as precursor cells for interferon-gamma-producing killer T cells.
    Kosaka A; Lee U; Wakita D; Matsubara N; Togashi Y; Nishimura S; Kitamura H; Nishimura T
    Cancer Sci; 2006 Nov; 97(11):1236-41. PubMed ID: 16952305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel probably enhances cytotoxicity of natural killer cells against breast carcinoma cells by increasing perforin production.
    Kubo M; Morisaki T; Matsumoto K; Tasaki A; Yamanaka N; Nakashima H; Kuroki H; Nakamura K; Nakamura M; Katano M
    Cancer Immunol Immunother; 2005 May; 54(5):468-76. PubMed ID: 15592829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-12 regulates the expansion, phenotype, and function of murine NK cells activated by IL-15 and IL-18.
    Oka N; Markova T; Tsuzuki K; Li W; El-Darawish Y; Pencheva-Demireva M; Yamanishi K; Yamanishi H; Sakagami M; Tanaka Y; Okamura H
    Cancer Immunol Immunother; 2020 Sep; 69(9):1699-1712. PubMed ID: 32333080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-150 regulates the cytotoxicity of natural killers by targeting perforin-1.
    Kim N; Kim M; Yun S; Doh J; Greenberg PD; Kim TD; Choi I
    J Allergy Clin Immunol; 2014 Jul; 134(1):195-203. PubMed ID: 24698324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotype and function of human natural killer cells purified by using a clinical-scale immunomagnetic method.
    Leung W; Iyengar R; Leimig T; Holladay MS; Houston J; Handgretinger R
    Cancer Immunol Immunother; 2005 Apr; 54(4):389-94. PubMed ID: 15449041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Fusion Protein Complex that Combines IL-12, IL-15, and IL-18 Signaling to Induce Memory-Like NK Cells for Cancer Immunotherapy.
    Becker-Hapak MK; Shrestha N; McClain E; Dee MJ; Chaturvedi P; Leclerc GM; Marsala LI; Foster M; Schappe T; Tran J; Desai S; Neal CC; Pence P; Wong P; Wagner JA; Russler-Germain DA; Zhu X; Spanoudis CM; Gallo VL; Echeverri CA; Ramirez LL; You L; Egan JO; Rhode PR; Jiao JA; Muniz GJ; Jeng EK; Prendes CA; Sullivan RP; Berrien-Elliott MM; Wong HC; Fehniger TA
    Cancer Immunol Res; 2021 Sep; 9(9):1071-1087. PubMed ID: 34244297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perforin-dependent direct cytotoxicity in natural killer cells induces considerable knockdown of spontaneous lung metastases and computer modelling-proven tumor cell dormancy in a HT29 human colon cancer xenograft mouse model.
    Brodbeck T; Nehmann N; Bethge A; Wedemann G; Schumacher U
    Mol Cancer; 2014 Nov; 13():244. PubMed ID: 25373310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cordyceps sinensis extract protects against acute kidney injury by inhibiting perforin expression in NK cells via the STING/IRF3 pathway.
    Li S; Pang W; Wang Y; Zhang Y
    Aging (Albany NY); 2024 Mar; 16(7):5887-5904. PubMed ID: 38517396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fate control engagement augments NK cell responses in LV/hu-IL-12 transduced sarcoma.
    Rademacher MJ; Faber ML; Bone KM; Medin JA; Schloemer NJ
    Exp Mol Pathol; 2024 Jun; 137():104898. PubMed ID: 38729059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Obese Liver Environment Mediates Conversion of NK Cells to a Less Cytotoxic ILC1-Like Phenotype.
    Cuff AO; Sillito F; Dertschnig S; Hall A; Luong TV; Chakraverty R; Male V
    Front Immunol; 2019; 10():2180. PubMed ID: 31572388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The introduction of RNA-DNA differences underlies interindividual variation in the human IL12RB1 mRNA repertoire.
    Turner AJ; Aggarwal P; Miller HE; Waukau J; Routes JM; Broeckel U; Robinson RT
    Proc Natl Acad Sci U S A; 2015 Dec; 112(50):15414-9. PubMed ID: 26621740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune and inflammatory mechanisms in hypertension.
    Guzik TJ; Nosalski R; Maffia P; Drummond GR
    Nat Rev Cardiol; 2024 Jun; 21(6):396-416. PubMed ID: 38172242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Update Immune-Regulatory Role of Pro- and Anti-Inflammatory Cytokines in Recurrent Pregnancy Losses.
    Yang X; Tian Y; Zheng L; Luu T; Kwak-Kim J
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innate lymphoid cells in early tumor development.
    Warner K; Ghaedi M; Chung DC; Jacquelot N; Ohashi PS
    Front Immunol; 2022; 13():948358. PubMed ID: 36032129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune response against toxoplasmosis-some recent updates RH:
    Sana M; Rashid M; Rashid I; Akbar H; Gomez-Marin JE; Dimier-Poisson I
    Int J Immunopathol Pharmacol; 2022; 36():3946320221078436. PubMed ID: 35227108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.